好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Everolimus long-term safety and efficacy in patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): final analysis of a phase 2 study
Child Neurology and Developmental Neurology
(-)
008
Authors/Disclosures
David N. Franz, MD (CCHMC/MLC 2015)
PRESENTER 		No disclosure on file
No disclosure on file
Katherine D. Holland, MD, PhD (Cincinnati Children's Hospital) No disclosure on file
Karen Agricola, FNP No disclosure on file
No disclosure on file
Noah Berkowitz No disclosure on file
No disclosure on file
No disclosure on file
Darcy Krueger, MD (Cincinnati Children'S Hospital Medical Center) Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NobelPharma USA. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for RegenxBio. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Pharmaceuticals. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Greenwich Biosciences. The institution of Dr. Krueger has received research support from Greenwich Bioscience. The institution of Dr. Krueger has received research support from Marinus Pharmaceuticals. The institution of Dr. Krueger has received research support from National Institutes of Health. The institution of Dr. Krueger has received research support from Food and Drug Administration. The institution of Dr. Krueger has received research support from TSC Alliance.